Home Starget Pharma

Starget Pharma

In operation
Series A
Developer of Peptide-based Radioligand Therapy

Basic Information

Starget Pharma specializes in the diagnosis and targeted treatment of cancer using targeted radioactive radiation. The company’s research focuses on developing molecules that act as carriers to deliver radioactive isotopes specifically to cancer tumors with unmet medical needs, enabling doctors and healthcare practitioners to provide effective cancer treatments.
Starget Pharma Ltd.
TelAvivDistrict,Israel
less than 15 people
January 01, 2019
--